About DermaSensor
DermaSensor is a medical technology company that develops AI-driven solutions for early skin cancer detection at the point of care. The company's flagship product is an FDA-cleared, handheld device that combines advanced optical spectroscopy with artificial intelligence to analyze suspicious skin lesions in real-time. The device delivers results in approximately 30 seconds, helping healthcare professionals assess the malignancy risk of skin lesions with 96% sensitivity across the three most common types of skin cancer: melanoma, squamous cell carcinoma, and basal cell carcinoma. The DermaSensor device uses Elastic Scattering Spectroscopy (ESS) technology, which has been validated in over 30 publications across various tissue types. The device's tip reflects and records quick bursts of light off the lesion's cellular and sub-cellular content, which is then analyzed by a built-in computer using proprietary algorithms developed and refined over a decade of clinical research. These algorithms have been trained on thousands of diagnosed lesions to provide an immediate 'Investigate Further' or 'Monitor' output based on the lesion's malignancy risk level. DermaSensor serves a wide range of healthcare specialties including family medicine, internal medicine, concierge practices, health systems, and walk-in clinics. The company's mission is to empower healthcare professionals with data-driven, breakthrough solutions that improve early skin cancer detection and save lives. The technology is particularly valuable in addressing the challenge of long wait times for dermatology referrals, which can range from 4-6 months in many areas, and helps non-dermatology physicians enhance their clinical confidence in skin cancer assessment. The device has been integrated into medical training programs and is supported by 15 development, validation, and clinical utility studies involving 5,000 scanned and diagnosed lesions.
Mission & Story
Mission
DermaSensor's mission is to empower healthcare professionals with data-driven, breakthrough solutions that improve early skin cancer detection and save lives.
Clinical Focus
Medical conditions and clinical areas addressed by DermaSensor.
Who It Serves
Milestones & Awards
Recent Milestones
Integration into Florida State University Family Medicine Residency Program at BayCare Health System for resident training. Reimbursement assistance now available for the device.
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.